The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand Vertex Pharmaceuticals forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of ...